BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 34806311)

  • 1. Enhancement of CD8
    Zhang Y; Gao X; Yan B; Wen N; Lee WSV; Liang XJ; Liu X
    ChemMedChem; 2022 Jan; 17(2):e202100656. PubMed ID: 34806311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetism-mediated targeting hyperthermia-immunotherapy in "cold" tumor with CSF1R inhibitor.
    Fang Y; He Y; Wu C; Zhang M; Gu Z; Zhang J; Liu E; Xu Q; Asrorov AM; Huang Y
    Theranostics; 2021; 11(14):6860-6872. PubMed ID: 34093858
    [No Abstract]   [Full Text] [Related]  

  • 3. Ferrimagnetic Vortex Nanoring-Mediated Mild Magnetic Hyperthermia Imparts Potent Immunological Effect for Treating Cancer Metastasis.
    Liu X; Zheng J; Sun W; Zhao X; Li Y; Gong N; Wang Y; Ma X; Zhang T; Zhao LY; Hou Y; Wu Z; Du Y; Fan H; Tian J; Liang XJ
    ACS Nano; 2019 Aug; 13(8):8811-8825. PubMed ID: 31328922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic nanoparticles and clusters for magnetic hyperthermia: optimizing their heat performance and developing combinatorial therapies to tackle cancer.
    Gavilán H; Avugadda SK; Fernández-Cabada T; Soni N; Cassani M; Mai BT; Chantrell R; Pellegrino T
    Chem Soc Rev; 2021 Oct; 50(20):11614-11667. PubMed ID: 34661212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Advances in Hyperthermia Therapy-Based Synergistic Immunotherapy.
    Chang M; Hou Z; Wang M; Li C; Lin J
    Adv Mater; 2021 Jan; 33(4):e2004788. PubMed ID: 33289219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local hyperthermia treatment of tumors induces CD8(+) T cell-mediated resistance against distal and secondary tumors.
    Toraya-Brown S; Sheen MR; Zhang P; Chen L; Baird JR; Demidenko E; Turk MJ; Hoopes PJ; Conejo-Garcia JR; Fiering S
    Nanomedicine; 2014 Aug; 10(6):1273-1285. PubMed ID: 24566274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron Nanoparticles for Low-Power Local Magnetic Hyperthermia in Combination with Immune Checkpoint Blockade for Systemic Antitumor Therapy.
    Chao Y; Chen G; Liang C; Xu J; Dong Z; Han X; Wang C; Liu Z
    Nano Lett; 2019 Jul; 19(7):4287-4296. PubMed ID: 31132270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy.
    Yang Q; Shi G; Chen X; Lin Y; Cheng L; Jiang Q; Yan X; Jiang M; Li Y; Zhang H; Wang H; Wang Y; Wang Q; Zhang Y; Liu Y; Su X; Dai L; Tang M; Li J; Zhang L; Qian Z; Yu D; Deng H
    Theranostics; 2020; 10(18):8382-8399. PubMed ID: 32724476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mild Magnetic Hyperthermia-Activated Innate Immunity for Liver Cancer Therapy.
    Pan J; Xu Y; Wu Q; Hu P; Shi J
    J Am Chem Soc; 2021 Jun; 143(21):8116-8128. PubMed ID: 33928777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of NIR therapy and regulatory T cell modulation using layer-by-layer hybrid nanoparticles for effective cancer photoimmunotherapy.
    Ou W; Jiang L; Thapa RK; Soe ZC; Poudel K; Chang JH; Ku SK; Choi HG; Yong CS; Kim JO
    Theranostics; 2018; 8(17):4574-4590. PubMed ID: 30279723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperthermia generated by magnetic nanoparticles for effective treatment of disseminated peritoneal cancer in an orthotopic nude-mouse model.
    Matsumi Y; Kagawa T; Yano S; Tazawa H; Shigeyasu K; Takeda S; Ohara T; Aono H; Hoffman RM; Fujiwara T; Kishimoto H
    Cell Cycle; 2021 Jun; 20(12):1122-1133. PubMed ID: 34110969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive understanding of magnetic hyperthermia for improving antitumor therapeutic efficacy.
    Liu X; Zhang Y; Wang Y; Zhu W; Li G; Ma X; Zhang Y; Chen S; Tiwari S; Shi K; Zhang S; Fan HM; Zhao YX; Liang XJ
    Theranostics; 2020; 10(8):3793-3815. PubMed ID: 32206123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immuno-hyperthermia effected by antibody-conjugated nanoparticles selectively targets and eradicates individual cancer cells.
    Kagawa T; Matsumi Y; Aono H; Ohara T; Tazawa H; Shigeyasu K; Yano S; Takeda S; Komatsu Y; Hoffman RM; Fujiwara T; Kishimoto H
    Cell Cycle; 2021 Jul; 20(13):1221-1230. PubMed ID: 34148497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid tumor inhibition via magnetic hyperthermia regulated by caspase 3 with time-dependent clearance of iron oxide nanoparticles.
    Chauhan A; Midha S; Kumar R; Meena R; Singh P; Jha SK; Kuanr BK
    Biomater Sci; 2021 Apr; 9(8):2972-2990. PubMed ID: 33635305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
    Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
    Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in functionalized ferrite nanoparticles: From fundamentals to magnetic hyperthermia cancer therapy.
    Zhang L; Li Q; Liu J; Deng Z; Zhang X; Alifu N; Zhang X; Yu Z; Liu Y; Lan Z; Wen T; Sun K
    Colloids Surf B Biointerfaces; 2024 Feb; 234():113754. PubMed ID: 38241891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8
    Farhood B; Najafi M; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8509-8521. PubMed ID: 30520029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic Cells and CD8 T Cell Immunity in Tumor Microenvironment.
    Fu C; Jiang A
    Front Immunol; 2018; 9():3059. PubMed ID: 30619378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase-transition nanodroplets with immunomodulatory capabilities for potentiating mild magnetic hyperthermia to inhibit tumour proliferation and metastasis.
    Qin Q; Zhou Y; Li P; Liu Y; Deng R; Tang R; Wu N; Wan L; Ye M; Zhou H; Wang Z
    J Nanobiotechnology; 2023 Apr; 21(1):131. PubMed ID: 37069614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin k3-Loaded Magnetic Nanoparticle-Mediated Synergistic Magnetothermodynamic Therapy Evokes Massive ROS and Immune Modulation for Augmented Antitumor Potential.
    Chauhan A; Anjaly K; Saini A; Kumar R; Kuanr BK; Sharma D
    ACS Appl Mater Interfaces; 2023 Jun; 15(23):27515-27532. PubMed ID: 37264797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.